Encompass Health CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
Encompass Health Corporation announced a 9.6% increase in net operating revenues for the second quarter of 2026, driven by volume growth and favorable pricing, alongside a significant rise in net income.
NYSE
Encompass Health reported a 9% increase in net operating revenues for Q1 2026, driven by volume growth and pricing improvements.
NYSE
Encompass Health delivered double‑digit year‑to‑date growth, expanded capacity, redeemed 2025 notes, and flagged a 2.9% Medicare rate lift effective October 1 while noting ongoing RCD audit risk.
NYSE
Encompass Health Corporation announced significant revenue and earnings growth for Q2 2025, driven by increased patient volumes and favorable pricing, alongside strategic expansion and a dividend increase.
NYSE
Encompass Health Corporation reports a 10.6% increase in net operating revenues for the first quarter of 2025, driven by volume growth and increased pricing.
NYSE
Encompass Health Corporation reported a significant increase in net operating revenues for the third quarter of 2024, primarily driven by volume growth.
NYSE
Encompass Health Corporation reported a 9.6% increase in net operating revenues for the second quarter of 2024, primarily driven by volume growth.
NYSE
Encompass Health's first quarter results show a significant increase in net operating revenues, primarily driven by a 13.4% increase in volume growth.